ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.
Cancer Immunol Res
; 2(7): 679-89, 2014 Jul.
Article
in En
| MEDLINE
| ID: mdl-24844911
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma, Kaposi
/
Down-Regulation
/
MAP Kinase Signaling System
/
Receptors, CCR10
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Immunol Res
Year:
2014
Document type:
Article
Country of publication:
United States